Quick analysis of the Combimed US Equities daily chart...
A significant rebound last week put the closing back into the decision box. Thing is, it went out the other end, as expected it would, BUT ended with a doji (indecision candlestick) and came back into the box... which suggest an exit to thru the lower end. This is abou to happen over the last days of the 2024.
And IF it exceeds the last low, then it is a tell all that 2025 is not going to be bullishly exciting.
In any case, a good retracement is overdue and likely comes in 1Q2025
Technicals here show weakening MACD and a decelerating rate of VolDiv.
Let's see how bullisht the first day of 2025 and the first week of 2025 can be... not terribly optimistic IMHO.
In any case... HAPPY NEW YEAR 2025 everyone!
Stay safe and stay happy!
A significant rebound last week put the closing back into the decision box. Thing is, it went out the other end, as expected it would, BUT ended with a doji (indecision candlestick) and came back into the box... which suggest an exit to thru the lower end. This is abou to happen over the last days of the 2024.
And IF it exceeds the last low, then it is a tell all that 2025 is not going to be bullishly exciting.
In any case, a good retracement is overdue and likely comes in 1Q2025
Technicals here show weakening MACD and a decelerating rate of VolDiv.
Let's see how bullisht the first day of 2025 and the first week of 2025 can be... not terribly optimistic IMHO.
In any case... HAPPY NEW YEAR 2025 everyone!
Stay safe and stay happy!
Publications connexes
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
Publications connexes
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.